B
BRAVEHEART BIO, INC. COMMON STOCK
NASDAQ: BRVE (Braveheart Bio, Inc.)
最近更新时间: 7小时之前21.44
-0.04 (-0.19%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Braveheart Bio, Inc. | - | - |
AIStockmoo 评分
0.3
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | -2.0 |
| 相对估值 | NA |
| 财务健康 | NA |
| AI Insight | NA |
| 平均 | 0.25 |
|
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
该时间范围内无数据。
AI 技术分析
打开“技术”标签以生成最新分析。
投资组合